In-Person12.8 CE CreditsExhibit Opportunities

25th Annual Psychopharmacology Update

Hosted by MedscapeLIVE!

Oct 23–24, 2026 Hyatt Regency Cincinnati, Cincinnati, Ohio

Health & Social Care

About This Event

This is a two-day psychiatry conference focusing on evidence-based psychopharmacology for treatment-resistant psychiatric conditions. The program features world-renowned faculty presenting the latest clinical strategies and therapeutic breakthroughs for managing difficult-to-treat psychiatric disorders across multiple diagnostic categories, including substance use disorders, eating disorders, personality disorders, anxiety, mood disorders, psychosis, ADHD, and autism spectrum disorders.

Topics Covered

Addiction & Substance Use

Alcohol Use DisorderSubstance Use DisordersEmerging DrugsGambling & Process AddictionsOpioid Prescribing (DEA)

Pain Management

Chronic Pain

Geriatrics & Aging

Polypharmacy

Regulatory & Legal

Controlled Substance Management

Venue

Hyatt Regency Cincinnati

Cincinnati, Ohio, 45202

View on Google Maps

Registration & Fees

Early Bird Rate

$299

Before Mar 31, 2026

Continuing Education

12.8 CE Credits

Accredited by: Accreditation Council for Continuing Medical Education (ACCME)

12.75 AMA PRA Category 1 Credits for physicians; 12.75 contact hours for nurses; 12.75 contact hours (1.275 CEUs) for pharmacy; 12.75 AAPA Category 1 CME credits for physician assistants; 12.75 Interprofessional Continuing Education (IPCE) credit. ABPN Diplomates may select any CME activity relevant to their practice to count towards ABPN MOC requirements.

Who This Event Is For

Industries

Health & Social Care

Professional Fields

Medical & Direct CareMental Health & CounselingNursing & Advanced PracticePharmacy Professionals

Professions

PhysiciansPsychiatristsPhysician AssistantPsychologistsPsychiatric NursesMental Health CounselorsNurse PractitionersRegistered NursesPharmacists

Who Can Attend

Open To All

Target Audience

Psychiatrists, physicians, nurse practitioners, physician assistants, registered nurses, residents, and other mental health professionals involved in psychopharmacological treatment